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Abstract
Human BK polyomavirus (BKV) is reactivated under conditions of immunosuppression leading most commonly
to nephropathy or cystitis; its tropism for the brain is rare and poorly understood. We present a unique case of
BKV-associated encephalopathy in a man with hypohidrotic ectodermal dysplasia and immunodeficiency (HED-ID)
due to IKK-gamma (NEMO) mutation, who developed progressive neurological symptoms. Brain biopsy demonstrated
polyomavirus infection of gray and white matter, with predominant involvement of cortex and distinct neuronal tropism,
in addition to limited demyelination and oligodendroglial inclusions. Immunohistochemistry demonstrated polyoma
T-antigen in neurons and glia, but expression of VP1 capsid protein only in glia. PCR analysis on both brain biopsy tissue
and cerebrospinal fluid detected high levels of BKV DNA. Sequencing studies further identified novel BKV variant and
disclosed unique rearrangements in the noncoding control region of the viral DNA (BKVN NCCR). Neuropathological
analysis also demonstrated an unusual form of obliterative fibrosing vasculopathy in the subcortical white matter with
abnormal lysosomal accumulations, possibly related to the patient’s underlying ectodermal dysplasia. Our report provides
the first neuropathological description of HED-ID due to NEMO mutation, and expands the diversity of neurological
presentations of BKV infection in brain, underscoring the importance of its consideration in immunodeficient
patients with unexplained encephalopathy. We also document novel BKVN NCCR rearrangements that may be
associated with the unique neuronal tropism in this patient.
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Background
Here we report the first histological description of BK
virus encephalopathy with cortical predominance in a
male patient with hypohidrotic ectodermal dysplasia
and immunodeficiency (HED-ID), a rare X-linked dis-
order due to mutation in the NFkB signaling pathway.
Ectodermal dysplasias are a group of inherited disor-
ders characterized by absence or dysplasia of ectoder-
mal appendages. In the hypohidrotic form, there is
abnormal development of eccrine sweat glands, teeth,
and hair [23]. Mutations within a regulatory subunit of
the NFkB pathway, IKK-gamma/NF-kappa-B essential
modulator (NEMO), are known to cause two distinct
X-linked forms of ectodermal dysplasia: X-linked domin-
ant familial incontinentia pigmenti (IP), which is typically
fatal prenatally in males; and X-linked recessive disorder
with rare combination of HED and immunodeficiency
(HED-ID), in which incomplete loss of NEMO function
leads to impaired immune response with recurrent
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bacterial and viral infections in addition to HED [2, 17, 21,
30, 46, 50, 59]. Herein, we demonstrate BKV encephalop-
athy by histology, immunohistochemistry, sequencing, and
further characterize a novel BKV variant (BKVN), which
harbors unique rearrangements in the noncoding control
region (NCCR), potentially contributing to its neuronal
tropism. Finally, we describe several other previously unre-
ported neuropathological features in this patient in the
context of his underlying HED-ID disorder.
Polyomaviruses are non-enveloped, small (~40 nm) vi-
ruses with a circular double-stranded DNA genome. BK
polyomavirus (BKV) displays approximately 75 % DNA
homology with JC polyomavirus (JCV) and 70 % hom-
ology with the simian polyomavirus SV40. Infection with
BKV occurs during childhood and is usually asymptom-
atic. Thereafter, the virus enters a state of latency, predom-
inantly in the renal tubular epithelial cells, during which
BKV DNA can be detected, while viral proteins such as T-
antigen, agnoprotein and capsid proteins, cannot. By adult-
hood, 80–90 % of the general population is persistently
colonized with BKV [31, 32]. Reactivation of the latent
virus occurs predominantly in patients with impaired
immune function, including HIV-1/AIDS, lymphoprolifer-
ative disorders and other malignancies, and treatment with
immunosuppressive drugs [10, 48]. The most common
pathologic conditions associated with reactivation of BKV
are polyomavirus-associated nephropathy or PVAN in
kidney transplant recipients [13, 14, 52] and hemorrhagic
cystitis in bone marrow transplant recipients [3, 31]. Less
often, BKV is reported to cause fatal pneumonia, retinitis,
native kidney nephritis, and only rarely meningoencephal-
itis in the severely immunocompromised [12, 16, 54]. JC
polyomavirus, rather than BK, is by far the most com-
monly associated virus with a CNS tropism in the context
of immunosuppression, causing a progressive multifocal
demyelinating leukoencephalopathy (PML) [29].
Case presentation
A 29-year-old man had been diagnosed with immunodefi-
ciency at the age of one year after developing recurrent
bacterial and viral infections in the setting of dysgamma-
globulinemia with low levels of IgG. He also displayed
signs of ectodermal dysplasia, including conical-shaped
incisors, hypodontia and inadequate sweating. After mul-
tiple recurrent infections, at the age of 12, the patient was
diagnosed with HED-ID caused by NEMO deficiency.
Genomic analysis revealed a missense mutation within the
putative zinc-finger domain in the most 3′ exon of IKK-
gamma - exon 10, causing a cysteine to arginine substitu-
tion [2, 59]. Notably, the patient’s older brother had very
similar clinical presentation and passed away at the age
of 17 with recurrent bronchiectasis after bilateral lung
transplantation. Following diagnosis of HED-ID in the
reported patient, lifelong IVIG treatment was initiated
and maintained, leading to stabilization of IgG levels
and a normal quality of life.
At the age of 29, the patient experienced new-onset
neurological symptoms including left homonymous hemi-
anopsia and intermittent, pressure-like headache, without
significant motor, sensory, or cognitive impairment. Initial
MRI of the brain (Fig. 1a, b) showed multiple scattered
foci of increased T2 FLAIR signal, restricted diffusion, and
contrast enhancement, predominantly within the right
occipital lobe (likely contributing to the patient’s visual
changes). Additional small foci of increased T2 FLAIR sig-
nal were seen within the left frontal lobe, left thalamus,
left pons and medulla. The varied, bilateral sites of radio-
graphic abnormality suggested a possible embolic process,
but infectious and non-infectious inflammatory processes
were also considered in the differential. Extensive imaging
workup failed to reveal an embolic source, and cultures of
blood, urine, and cerebrospinal fluid (CSF) did not dem-
onstrate bacterial, viral or fungal organisms. The patient’s
neurological status continued to deteriorate over the next
3 months with progressive disorientation and cognitive
decline. Follow-up MRIs now showed further disease pro-
gression with more extensive involvement of both occipi-
tal lobes, prominent involvement of the cortex and
subcortical white matter of both frontal lobes (Fig. 1c, d),
and expanded involvement of the left thalamus and brain-
stem (Fig. 1e). CSF studies remained negative for bacteria,
fungal elements, and a variety of viral pathogens (adeno-
virus, enterovirus, HSV1, HSV2, CMV, VZV, EBV, HHV6,
and West Nile, East Equine encephalitis, and St. Louis en-
cephalitis arboviruses). CSF PCR for JCV was negative on
two separate occasions. Approximately three months after
initial presentation, a targeted right occipital brain biopsy
was performed for definitive diagnosis.
Histological examination of the biopsy specimen revealed
a chronic inflammatory process involving the leptomenin-
ges, underlying cortex and white matter (Fig. 2). The neo-
cortex appeared distinctly abnormal, with widespread
architectural neuronal disorganization, vacuolization most
prominent in the external pyramidal layer III, reactive vas-
culature, astrogliosis and microglial activation (Fig. 2a-f).
Many cortical neurons showed bizarre dysmorphic fea-
tures, including increased size, displaced Nissl substance,
vacuolization, and clustering (Fig. 2b, d), abnormal neuro-
filament accumulation in the cell body (Fig. 2e), and occa-
sionally tuft-like ramified CD34-positive processes (Fig. 2f).
In the subcortical white matter there was robust multifocal
vacuolization (Fig. 2g-j) with minimal associated myelin
loss (Fig. 2h, j), and a prominent chronic perivascular and
intraparenchymal inflammatory infiltrate composed of
CD68+ macrophage/microglia and CD3+ T-lymphocytes
(Fig. 2k-m). Scattered bizarre oligodendroglial-like cells
with enlarged nuclei were noted, frequently contain-
ing glassy, homogeneous nuclear inclusions (Fig. 2i,
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arrows); Creutzfeldt-like astrocytes were also seen
(Fig. 2j, arrowhead).
Immunohistochemical studies with anti-SV40 T-Antigen,
which cross-reacts with JC and BK virus T-antigens,
showed strong nuclear positivity in cortical neurons,
predominantly in layers II-V (Fig. 3a) as well as in scat-
tered enlarged oligodendroglial and astrocytic nuclei with
bizarre multilobated appearance (Fig. 3b). The predomin-
ant morphology of infected cells in the cortex resembled
pyramidal neurons, although infection of other neuronal
cell populations could not be excluded. SV40 T-antigen
was not identified in the leptomeninges, which otherwise
appeared markedly fibrotic and expanded by chronic in-
flammatory infiltrate (Fig. 2a, c).
We also analyzed expression of the polyomavirus VP1
capsid protein using an antibody that cross-reacts with
VP1 of JCV, BKV and SV40. Intriguingly, the number of
cells positive for VP1 was significantly lower compared
to T-antigen positive cells in the same region (Fig. 3c-d).
Noticeably, VP1-immunoreactivity was associated with
cells of oligodendroglial or astrocytic phenotype (Fig. 3d)
but was largely absent in infected neurons (Fig. 3c).
Electron microscopy confirmed the presence of 30–
40 nm non-enveloped icosahedral viral particles within
the nuclear chromatin, consistent with polyomavirus
(Fig. 3e-f ).
Detection of JC virus DNA by PCR, the most common
polyomavirus to infect the brain, was unsuccessful both
in CSF prior to the brain biopsy as well as in the patho-
logical cortical tissue. We therefore considered the pos-
sibility of infection by other polyomavirus species, and
performed targeted qPCR for BKV at the CLIA/NINDS
laboratory [45], which detected a high titer of BK virus
within the CSF and biopsy tissue.
The double-stranded circular DNA of the BKV genome
contains approximately 5100 base pairs arranged around
the cellular histones and is comprised of three parts: the
early and late coding regions for regulatory and structural
proteins that are transcribed in opposite directions, and a
bidirectional NCCR located between the early and late cod-
ing regions. The early coding region encodes the regulatory
proteins large and small tumor antigens, the truncated
tumor antigen and a pre-miRNA for two miRNAs [1, 47].
The late coding region encodes the regulatory agnopro-
tein and the three structural capsid proteins VP1, VP2
and VP3. The NCCR controls the initiation of viral
DNA synthesis and regulates the transcription of early
and late promoters [18, 57]. To further analyze the VP1
and NCCR regions of our specific BKV variant for se-
quence motifs in the context of its unique neuronal
tropism, we performed a two-step nested PCR amplifi-
cation followed by Sanger sequencing of BKV VP1 and
NCCR (Fig. 4, Additional file 1: Figure S1). The major
capsid protein of BK virus, VP1, is involved in the inter-
action with host cellular receptors [42], but whether
specific VP1 polymorphisms are linked to neurological
sequelae of BKV is not clear. The NCCR region of BKV
contains binding motifs for numerous cellular transcription
Fig. 1 Serial axial T2 FLAIR MRI (a, c) and corresponding axial
contrast-enhanced T1 MRI (b, d) imaging of patient during initial
presentation and after three months of disease progression when
biopsy was performed. a Initial MRI (Day 1 of hospitalization) shows
cortical gray matter with increased T2 FLAIR signal that is most
prominent in the right occipital lobe (arrow) and just appreciable in
the left occipital lobe. The related sulci are prominent, not compressed.
The juxta-cortical white matter appears normal. b There is prominent
contrast enhancement of portions of the affected cortices with no
leptomeningeal enhancement. c-d Surveillance axial T2 FLAIR MRI
(c, Day 90 of hospitalization,) and contrast-enhanced T1 MRI (d, Day 82
of hospitalization,) show disease progression with prominent
involvement of both occipital and both frontal lobes. e T2 MRI
through the deep gray matter and brain stem (sagittal) on Day 81
of hospitalization demonstrates patchy regions with signal abnormality
in the basal ganglia, thalami and brain stem, including the medial left
thalamus, right lateral geniculate nucleus, inferior colliculus,
interpeduncular nuclei, dorsal pontine nuclei, and lateral medullary nuclei
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Fig. 2 Histological analysis of right occipital brain biopsy reveals unusual form of inflammatory encephalopathy. a-b Hematoxylin and eosin (H&E)
stains show chronic meningitis and neocortex with architectural neuronal disorganization, associated with reactive vasculature, gliosis, microglial
activation, and mild chronic inflammation. c CD3+ T-lymphocytes predominate in the meninges. d Many cortical neurons display dysmorphic features,
such as increased size, displaced Nissl substance, clustering, and e abnormal phosphorylated neurofilament accumulation in their cell body. f Tuft-like
ramified CD34-positive processes are also seen in the neocortex. g-j The subcortical white matter contains multifocal vacuolization associated with
minimal myelin loss on luxol fast blue (LFB) stain, and scattered bizarre oligodendroglial-like cells with enlarged nuclei containing glassy, homogeneous
nuclear inclusions (i, arrows) and Creutzfeldt-like astrocytes (j, arrowhead). k-m Prominent chronic perivascular and intraparenchymal inflammatory
infiltrate in the white matter is composed of CD68+ macrophage/microglia and CD3+ T-lymphocytes
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factors (TFs) regulating viral transcription and replication
[11, 36, 57].
Sequence analysis of the patient’s VP1-amplified frag-
ment (Additional file 1: Figure S1) showed high homology
(within a few single nucleotide variations) with BKV isolate
RU15 (GenBank: FR720320.1; 2153 - 2583 nucleotides)
and BKV Dunlop strain (GenBank: V01108.1; 2272 - 2697
nucleotides). The NCCR amplified fragment containing
the initial portion of early genes (203 bp with start codon
for large T-antigen) also showed high similarity to the
Dunlop strain.
We also compared the sequence of our entire NCCR
amplicon (432 bp) with the archetypal variant (non-rear-
ranged, WW, GI:4838415). In the most frequently seen
archetype BKV strain, NCCR has been arbitrarily divided
into five sequence blocks denoted O-143, P-68, Q-39, R-63
and S-63 where the numbers indicate base pairs [40, 41].
Block O contains the origin of replication (ori) and binding
sites for large T-antigen and TFs, including NFkB, CEBPβ
and SP1 [57]. The early and late gene promoters and en-
hancers are located in P, Q, R, and S blocks. The BKV
NCCR in our patient harbored significant deviations from
reported NCCR sequences, including four repeats of por-
tions of block P (two ΔP41 and two ΔP26) in addition to a
small insertion, deletions and single nucleotide variations.
Block O, in contrast, was conserved (Fig. 4). The P blocks
in our patient appeared in two variants consisting of 41
(ΔP41) and 25 (ΔP26) nucleotides. Each of these blocks
encompassed the initial portions of P block of archetype.
The P blocks were arranged in the alternating manner:
ΔP41 +ΔP26 followed by small adenine-rich fragment and
the second ΔP41 +ΔP26. After the second ΔP26, blocks Q
and R were present, although with nucleotide variations
and deletions. Block S was not identified, although we can-
not exclude the possibility that this region failed to amplify
(Fig. 4b). We also compared our sequence with previously
reported rearranged BKV isolates and observed the highest
homology with NCCR of BKV strains WWM13 (GenBank:
Fig. 3 Polyomavirus infection in cortex and white matter by immunohistochemistry and electron microscopy. a-b Immunostaining with the
cross-reacting polyomavirus antibody anti-SV40 T-Antigen shows strong nuclear positivity in cortical neurons, predominantly in layers II-V (a) and
in scattered enlarged oligodendroglial and astrocytic nuclei (b) in the white matter. c-d Immunoreactivity with the cross-reacting antibody anti-VP1
capsid protein is absent in cortical neurons (c) but is present in scattered cells with glial appearance in the white matter (d). e Electron micrographs
reveal a neural cell with aggregates of spherical particles admixed with chromatin (arrow), scale bar = 5 μm. f At higher power, 30–40 nm in diameter
non-enveloped icosahedral viral particles are observed, focally forming sheets and paracrystalline arrays (arrow); scale bar = 0.26 μm
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JQ513604.1) and WWM9 (GenBank: JQ513600.1). Intri-
guingly, these strains were isolated from the CSF of pa-
tients with neurological symptoms [4], implicating a
possible association between these BKV rearrangements
and predilection for CNS infection.
Detailed neuropathological analysis also demonstrated
an unusual form of sclerosing vasculopathy in the white
matter (Fig. 5), adjacent to but not involved by areas of in-
flammation and viral infection. We noted several thickened
vessels whose walls were entirely replaced by concentric
layers of collagen with uniquely associated perivascular la-
mellar fibrosis (Fig. 5d-e). These vessels lacked smooth
muscle fibers in their walls (Fig. 5c), and their lumina were
often completely obliterated with attempt at recanalization
(Fig. 5b). The vascular fibrosis showed unusual extension
into the adjacent brain parenchyma, revealing a dense,
reticulin-rich scar (Fig. 5e) almost completely devoid of
axonal processes. This angiocentric sclerosing process ap-
peared on a continuum, with some vessels outside of the
end-stage scar lesion showing milder collagen deposition
with preserved lumina and smooth muscle walls, but with
perivascular hemosiderin deposition, indicative of compro-
mised vascular wall integrity (Fig. 5b, inset). Small caliber
vessels with aberrant accumulation of lysosomal material
were identified on electron microscopy (Fig. 5f, arrow).
Discussion
We report a very unusual presentation of BK virus en-
cephalopathy in a patient with rare immunodeficiency
and ectodermal dysplasia due to NFkB dysfunction and
provide the first documented neuropathological descrip-
tion of this rare disorder, including the presence of
unique form of sclerosing vasculopathy.
To our knowledge, this is the first histological demon-
stration that BK virus can infect cortical neurons in man,
causing overwhelming encephalopathy with minimal
demyelination. CNS infection by BK virus is unusual
and clinically under-recognized, although a review of
the literature reveals descriptions of BKV-associated
encephalitis [7–9, 24, 35, 38, 55], meningoencephalitis
[12, 51, 53, 54], PML [15, 19], and retinitis [12, 26]. A
single report describes the neuropathological alterations
Fig. 4 Sequencing confirms BK virus infection in brain tissue and identifies unique BKVN NCCR region. a Sequence analysis of BKVN NCCR region.
Start codon for the late coding region is shown by red arrow. The origin of viral replication (ori) and TATA box are depicted. T-Ag binding sites
are underlined. The BKVN P blocks appear in two variants consisting of 41 (ΔP41) and 25 (ΔP26) nucleotides are shown in blue or red, respectively.
Each of these blocks is similar to the initial portion of P block of archetype. Insertions/variations are also highlighted (pink). b Schematic comparison of
NCCR sequence between BKV archetypal and BKVN. The NCCR region of the archetypal BKV contains five sequence blocks denoted O-143 (with ori),
P-68, Q-39, R-63 and S-63 where the numbers indicate base pairs. The BKVN NCCR contains block O-143, two tandem repeats composed of portions of
block P (ΔP41 and ΔP26) and separated by polyA stretch. Blocks Q and R follow the second ΔP26
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caused by BKV in the brain as marked perivascular and
leptomeningeal lymphocytic infiltration and patches of de-
myelination and gliosis [38]. These elements were also
present in our patient. Previous reports based on neuro-
imaging studies suggest that BKV infection has a predilec-
tion for the periventricular and pial surfaces of the brain
parenchyma, with the cortex being spared [37]. Our case
clearly demonstrates that BKV can also infect cortical neu-
rons leading to progressive encephalopathic symptomatol-
ogy, with only minimal demyelinating component at the
time of biopsy. Indeed, numerous pyramidal cortical neu-
rons in the occipital cortex of our patient showed strong
positivity for polyomavirus T-antigen but lacked staining
for VP1 capsid protein. Among polyomaviruses, the most
common one to infect the brain is JCV, which typically
causes a demyelinating disease with a productive and lytic
infection of oligodendrocytes and less commonly astro-
cytes [10, 20, 44]. Although predominant neuronal infec-
tion is rare, it has been reported in cerebellar granule cell
neurons as JC virus granule cell neuronopathy (JCV-
GCN), which is associated with JCV variants harboring
a small deletion in the VP1 capsid protein [22, 33], and
in cortical pyramidal neurons as JCV encephalopathy
(JCV-E), which is caused by JCV variants containing
Agno deletions [58]. Interestingly, in JCV-E more neu-
rons are positive for T-antigen, than for VP1 capsid pro-
tein, and it has been suggested that this phenomenon is
due to latent, recent, or abortive infection [58]. Similar
findings were reported in the occipital and temporal corti-
ces of a 21-year-old patient with common variable im-
munodeficiency, where the presence of JCV T-antigen
and P53, but not VP1 capsid protein, was detected in dys-
plastic ganglion-like cells [49]. Overall, our findings cor-
roborate that polyomaviruses can infect neurons, and
underscore the importance of considering BKV infection
in the differential diagnosis of immunosuppressed patients
with clinical symptoms of encephalopathy with undetect-
able JCV in their CSF.
Furthermore, we have identified a new BKV isolate with
significant rearrangements in its NCCR, which likely con-
tributed to the reactivation of the virus, in agreement with
numerous studies showing that the most rearranged strains
with deletions, insertions and duplications in NCCR are
associated with increased viral replication [25, 43]. We
speculate that the activation of BKV in an unusual host
compartment – here the neuronal cell - is dependent on
these unique NCCR rearrangements. This novel strain has
a quadruple enhancer element containing imperfect dupli-
cations of an archetypal P element. One possible mechan-
ism for viral activation and/or neuronal tropism may be
through selective amplification of TF motifs in this ampli-
fied P NCCR region, such as nuclear factor 1 (NF1) or SP1,
leading to transcriptional activation of viral genes necessary
for replication and/or neuronal infectivity. Further studies
are needed to characterize the exact role NCCR rearrange-
ments may play in BKV activation and neuronal tropism,
and the regulatory networks involved, which are beyond
the scope of this report.
Our detailed neuropathological analysis uncovered two
additional unusual features in the brain of this patient with
HED-ID, which may be related to his underlying ectoder-
mal dysplasia. The first one was the widespread presence
of dysplastic neurons throughout the occipital cortex bi-
opsy specimen. Many of these neurons showed T-antigen
immunoreactivity, suggesting that BKV infection may ac-
count for their dysmorphic appearance. Intriguingly, many
neurons immunoreactive for large T antigen were also
positive for p53, but not for capsid protein VP1. Previous
Fig. 5 Unusual form of sclerosing vasculopathy in HED-ID. a-b Hematoxylin and eosin stain shows vessels in the white matter with variably obliterated
lumina, hyalinization, and perivascular hemosiderin deposits (inset in b). c-d Concentric lamellated pattern of collagen accumulation is seen
on trichrome (c), extending into the adjacent brain parenchyma and forming a reticulin-rich scar (d). e Sclerotic vessels lack smooth muscle
fibers in their walls. f EM shows capillary vessel with aberrant accumulation of lysosomes (arrow); scale bar = 5 μm
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studies have suggested a possible role of T-antigen in the
dysplastic, ganglion cell-like change of the JCV infected
cortical neurons [49]. However, we found that more neu-
rons appeared dysplastic than showed immunohistochemi-
cal evidence of infection, raising the additional possibility
of an underlying cortical dysplasia superimposed on poly-
omavirus infection in this patient. In the absence of previ-
ous reports on the neuropathological effect of NEMO or
BKV on neurons and without further mechanistic studies,
it is not feasible to relate unequivocally the presence of
abnormal/dysplastic neurons to either BKV–associated
cytopathic effect or to HED-ID. The effect of NEMO
deficiency on cortical neuronal development has not
been previously scrutinized and it deserves further
consideration.
We also uncovered a unique sclerosing vasculopathy.
The fibrosing process had notable predilection for medium
sized vessels in the white matter, and manifested with ob-
literation of the vessel lumen and deposition of perivascu-
lar collagen in a lamellated pattern, which extended into
the surrounding brain parenchyma. As well, abnormal
accumulation of lysosomal material was noted within the
walls of some small-caliber vessels, which may be second-
ary to hypoxic stress or alternatively relate to a degen-
erative process. To our knowledge, the appearance of
this angiocentric fibrotic scar has not been previously
described in other CNS vasculopathic processes. We
believe it represents unique dysplastic pathology related
to the patient’s underlying ectodermal dysplasia and
herein provide its first neuropathological depiction in a
male patient with NEMO-deficiency.
There is very limited number of reports on the path-
ology of HED-ID. The first comprehensive study to de-
scribe pathological findings in 13 patients with HED-ID
(biopsies and autopsies) did not disclose any neuropatho-
logical abnormalities or features specific to NEMO defi-
ciency [28]. CNS findings in this study included agenesis
of the corpus callosum in one child, moderate-to-severe
cerebral atherosclerosis and hipopigmented substantia
nigra in one adult, a remote cerebral cortical infarct, cor-
tical ribbon defect and invasive cerebral aspergillosis in
another adult, and subacute and chronic inflammation in
the white matter of one living adult patient, without
further histological analyses. Skin biopsies were also ana-
lyzed in this study, describing mainly inflammatory patho-
logical findings (granulomatous dermatitis with positive
AFB staining, lobular panniculitis, seborrheic keratosis,
folliculitis) as well as abnormal vascular calcification in
two patients; there was no mention of fibrosing vasculopa-
thy and the presence of abnormal lysosomal accumula-
tions were not assessed. While our report is the first to
describe fibrosing vasculopathy in the brain of a patient
with HED-ID, abnormalities in CNS vessels have been
previously observed in patients with the closely related
NEMO-deficiency disorder in females, IP [6]. Brain MR
imaging studies in patients with IP have demonstrated
findings suggestive of microangiopathy [27, 34, 39]. Inter-
estingly, vascular sclerosis and occlusion with associated
fibrotic perivascular changes were reported in the ret-
ina of patients with IP [56]. The molecular mechanisms
underlying these vascular changes are not known, but
dysregulation of the NFkB signaling pathway is likely to
play a role.
Conclusion
BK polyomavirus encephalopathy is not typically con-
sidered in the differential diagnosis of patients with
neurological symptoms, and may be under-recognized
in immunosuppressed patients. We suggest that screen-
ing for BKV in the CSF of patients with encephalopathy
and undetectable JCV is of clinical importance. Our
study provides detailed neuropathological description
of the manifestation of BKV CNS infection with distinct
neuronal tropism in a patient with NFkB-mediated im-
munosuppression, expanding its clinical recognition. The
identified unique BKV sequence may be important for elu-
cidating the mechanisms of BK viral reactivation and neu-
rovirulence in future studies.
Materials and methods
Antibodies
Immunohistochemistry (IHC) was performed with the
following antibodies: mouse monoclonal anti-NeuN
(A60; MAB377; Chemicon), mouse monoclonal anti-
Neurofilament (2 F11, 760-2661, Ventana Medical Sys-
tems, Inc.), rabbit polyclonal anti- Glial Fibrillary Acidic
Protein (GFAP) (EP672Y; 760-4345, Ventana Medical Sys-
tems, Inc.), mouse monoclonal anti-p53 (DO-7, 790-2912,
Ventana Medical Systems, Inc.), rabbit monoclonal
anti-CD3 (2GV6, 790-4341, Ventana Medical Systems,
Inc.), mouse monoclonal anti-CD34 (QBEnd/10, 790-
2927, Ventana Medical Systems, Inc.), mouse monoclonal
anti-CD68 (KP-1, 790-2931, Ventana Medical Systems,
Inc.), SV40 T Ag (v-300; sc-20800, Santa Cruz Biotechnol-
ogy, Santa Cruz, CA) rabbit polyclonal antibody (raised
against amino acids 4-30 mapping near the N-terminus of
SV40 T Ag). Anti-VP1 antibody (mouse serum ab 597)
was kindly provided by Dr. Kamel Khalili (Department of
Neuroscience, Temple University School of Medicine,
Philadelphia, US).
Immunohistochemical staining
Paraffin embedded sections (4 μM) fixed in 10 % formalin
were deparaffinized in xylene, with subsequent rehydration
in a decreasing gradient of ethanol. Antigen retrieval was
performed using cell-conditioning solution 1 (Ventana
Medical Systems, AZ) for 60 min at 95 °C. After blocking,
sections were incubated with primary antibodies according
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manufacturer protocols. Sections were washed and incu-
bated with mouse or rabbit secondary antibodies depend-
ing on the type of the primary antibody on automated
strainers at room temperature (Ventana XT). Immunore-
activity was detected by means of the IVIEW or Ultraview
Universal DAB Detection Kits (760-500, Ventana Medical
Systems, AZ).
Electron microscopy
Small pieces of brain tissue were received fixed in 3 %
glutaraldehyde in a 0.2 M sodium cacodylate buffer at
pH 7.4. The tissue was treated with osmium tetroxide
for one hour rinsed in 0.2 M sodium cacodylate buffer
and then subjected to dehydration in increasing steps
of ethanol through propylene oxide and embedded in
embed 812. One-micrometer plastic sections were cut,
stained with methylene blue and Azure II, and observed
by light microscopy. Representative areas were chosen
for ultrathin sectioning. The thin sections were stained
with uranyl acetate and lead citrate and photographed
with a Hitachi H7650 transmission electron microscope
equipped with an SIA digital imaging system.
DNA isolation and sequencing
DNA extraction
DNA extraction was performed from 40 μl of fresh
frozen brain tissue using Qiagen QIAamp DNA kit (Cat.
#51304) and Qiagen ATL Buffer (Cat. #19076) according
to the manufacturer’s instructions. RNA Carrier (Qiagen
Cat. 1068337) was added to the sample to optimize DNA
yield. The DNA was eluted in a volume of 45 μl AE Buffer
and its concentration was measured using NanoDrop
2000.
Nested PCR amplification of VP1 and NCCR
sequences of BKV was performed as previously
described [4, 5], with slight modifications. Positions of
nucleotides for all primers are shown based on nucleo-
tide sequence in BKV Dunlop strain, V01108.
Amplification of the BKV VP1 region (nt 1456-2744)
In the first reaction, the following primers were used: for-
ward VP1-F1 5′-AAACTATTGCCCCAGGAGGT-3′ (nu-
cleotides (nt) 1456–1475) and reverse VP1-R4 5′-CTAA
AACACCACCCCCAAAA-3′ (nt 2725–2744). A 1289 bp
PCR products were purified by gel extraction using Qia-
gen QIAquick gel extraction kit (Qiagen, Cat. 28704)
and used for nested PCR with the following primers:
forward VP1-F4 5′-CTAATCAAAGAACTGCTCCTCAA
TG-3′ (nt 1477–1501) and reverse VP1-R8 5′-ACCACC
CCCAAAATAACACA-3′ (nt 2718–2737), producing an
amplicon of 1261 bp. Both reactions were performed in a
volume of 50 μl with 500 nM of each primer, 5 mM MgCl2,
500 μM dNTP’s, and 1.25 U of AmpliTaq Gold (Thermo-
Fisher, Cat. N8080248) and nuclease-free water. The first
PCR was performed on 2 μl eluted DNA. A 4 μl of the first
PCR product was used in the nested PCR. PCR conditions:
denaturation - 15 min at 94 °C, 40 cycles of 30 s at 94 °C,
30 s at 55.7 °C (65 °C for the nested PCR), and 60 s at 72 °C
with a final extension of 7 min at 72 °C.
Amplification of the BKV NCCR region (nt 4881-680)
In the first reaction, the following primers were used:
forward ORIBK1 5′-ATCTGGGCAAAGAGGAAAATC
A-3′ (nt 4881–4902) and reverse ORIBK2 5′-AGCAG
CCTCAGATACACTGG-3′ (nt 661–680). Nested PCR
was performed with Forward ORIBK3 5′-CAGGTT
CCAAAATCAGGCTG-3′ (nt 4924–4943) and reverse
ORIBK 5′-CTAGGAGTCTTTTACA-GAGTCT-3′ (nt
567–588) primers. For both amplification reactions,
AmpliTaq DNA polymerase with GeneAmp kit (Ther-
moFisher Cat. N8080248) including 1.25U of the poly-
merase were employed. A final volume of 50 μl was
completed with 500 nM of each primer, 500 μM of
dNTPs, 5 mM of MgCl2, nuclease-free water and 2 μl
of the DNA eluted (or 4 μl of the first PCR product for
the nested PCR). PCR conditions: denaturation 15 min at
95 °C, 40 cycles of 30 s at 94 °C, 30 s at 56 °C (58 °C for
the nested PCR), and 1 min at 72 ° with a final extension -
7 min at 72 °C. The amplicons were separated by electro-
phoresis on a 1 % agarose gel in the presence of ethidium
bromide and were visualized under UV light. To avoid
contamination, ultrapure reagents were added under a
laminar flow hood and in a separate room.
Consent
Informed consent was obtained from all individual par-
ticipants included in the study.
Additional file
Additional file 1: Targeted sequencing strategy for BKV VP1 and NCCR
regions. a. Products of nested PCR encompassing 1265 bp of BKV VP1
and 800 bp of NCCR with initial portion of early coding region are purified
from an 1 % agarose gel and submitted to Sanger sequencing. b. Sanger
sequencing results of VP1 and NCCR purified gel products. (PDF 427 kb)
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